Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-02-19 Sale |
2025-02-21 8:06 pm |
AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer |
33,936 | $301.56 | $10,233,748 | 36,922 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-17 Tax Withholding |
2025-03-19 8:22 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer |
3,635 | $313.71 | 40,702 (Direct) |
View |
2025-03-03 Option Award |
2025-03-05 8:08 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer |
7,277 | $0 | 44,199 (Direct) |
View |
2025-02-19 Exercise |
2025-02-21 8:06 pm |
2018-05-03 2026-05-03 |
AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer |
8,711 | $0 | 36,922 (Direct) |
View |
2025-02-19 Exercise |
2025-02-21 8:06 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer |
8,711 | $156.35 | 36,922 (Direct) |
View |
2024-05-07 Option Award |
2024-05-09 7:07 pm |
2026-05-07 2034-05-07 |
AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer |
20,767 | $300.3 | 82,656 (Direct) |
View |
2024-05-07 Option Award |
2024-05-09 7:07 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer |
3,196 | $0 | 82,656 (Direct) |
View |
2024-05-05 Tax Withholding |
2024-05-07 8:37 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer |
633 | $311.29 | 58,693 (Direct) |
View |
2024-05-02 Tax Withholding |
2024-05-03 7:24 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer |
650 | $277.37 | 59,326 (Direct) |
View |
2024-04-30 Tax Withholding |
2024-05-01 7:54 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer |
690 | $276.38 | 59,976 (Direct) |
View |
2024-03-18 Tax Withholding |
2024-03-20 8:11 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer |
6,202 | $268.87 | 60,666 (Direct) |
View |
2024-03-06 Option Award |
2024-03-08 5:32 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer |
12,407 | $0 | 66,653 (Direct) |
View |
2023-11-28 Gift |
2023-11-29 8:44 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
165 | $0 | 54,164 (Direct) |
View |
2023-05-05 Tax Withholding |
2023-05-09 7:24 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
594 | $231.89 | 54,114 (Direct) |
View |
2023-05-03 Tax Withholding |
2023-05-04 8:32 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
819 | $235.97 | 86,958 (Direct) |
View |
2023-05-02 Option Award |
2023-05-04 8:32 pm |
2025-05-02 2033-05-02 |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
36,064 | $0 | 86,958 (Direct) |
View |
2023-04-30 Tax Withholding |
2023-05-02 8:28 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
666 | $239.74 | 51,713 (Direct) |
View |
2023-03-17 Tax Withholding |
2023-03-20 7:14 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
3,978 | $234.57 | 52,379 (Direct) |
View |
2023-03-06 Option Award |
2023-03-08 7:04 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
7,947 | $0 | 56,167 (Direct) |
View |
2022-11-02 Tax Withholding |
2022-11-03 9:38 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
2,440 | $272.06 | 48,136 (Direct) |
View |
2022-05-05 Tax Withholding |
2022-05-09 7:12 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
575 | $236.1 | 50,307 (Direct) |
View |
2022-05-03 Tax Withholding |
2022-05-04 8:07 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
770 | $230.92 | 82,699 (Direct) |
View |
2022-05-02 Option Award |
2022-05-04 8:07 pm |
2024-05-02 2032-05-02 |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
35,714 | $0 | 82,699 (Direct) |
View |
2022-04-27 Tax Withholding |
2022-04-29 6:47 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
184 | $249.87 | 47,755 (Direct) |
View |
2022-03-18 Tax Withholding |
2022-03-22 5:47 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
4,995 | $235.86 | 47,939 (Direct) |
View |
2022-03-01 Option Award |
2022-03-03 7:33 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
9,989 | $0 | 52,714 (Direct) |
View |
2021-11-02 Tax Withholding |
2021-11-03 7:27 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
2,192 | $209.74 | 42,593 (Direct) |
View |
2021-05-01 Tax Withholding |
2021-05-04 7:41 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
1,854 | $239.64 | 79,254 (Direct) |
View |
2021-04-30 Option Award |
2021-05-04 7:41 pm |
2023-04-30 2031-04-30 |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
38,788 | $0 | 79,254 (Direct) |
View |
2021-04-27 Tax Withholding |
2021-04-28 8:17 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
174 | $255.52 | 42,320 (Direct) |
View |
2021-03-19 Tax Withholding |
2021-03-22 6:34 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
1,401 | $244.42 | 42,494 (Direct) |
View |
2021-03-02 Option Award |
2021-03-04 8:35 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
2,803 | $0 | 43,715 (Direct) |
View |
2021-02-16 Exercise |
2021-02-16 8:59 pm |
2013-04-25 2021-04-25 |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
2,300 | $0 | 40,912 (Direct) |
View |
2021-02-16 Tax Withholding |
2021-02-16 8:59 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
1,147 | $237.21 | 40,912 (Direct) |
View |
2021-02-16 Exercise |
2021-02-16 8:59 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
2,300 | $54.69 | 40,912 (Direct) |
View |
2020-11-02 Tax Withholding |
2020-11-04 7:06 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
2,125 | $216.94 | 39,619 (Direct) |
View |
2020-05-05 Option Award |
2020-05-07 9:04 pm |
2022-05-05 2030-05-05 |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
32,519 | $0 | 70,458 (Direct) |
View |
2020-05-03 Tax Withholding |
2020-05-05 7:57 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
185 | $230.98 | 37,939 (Direct) |
View |
2020-05-01 Tax Withholding |
2020-05-05 7:57 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
1,046 | $239.22 | 37,939 (Direct) |
View |
2020-04-27 Tax Withholding |
2020-04-29 7:04 pm |
N/A N/A |
AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development |
168 | $236.28 | 39,170 (Direct) |
View |